KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Change in substantial holding, page-14

  1. 351 Posts.
    lightbulb Created with Sketch. 51
    This is an excerpt from the About section of one of their latest ASX announcements...

    ”Chimeric Therapeutics is currently in a phase 1 clinical trial for its lead asset, CLTX-CAR T. “

    It clearly states in the trial.


 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.